skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal of clinical oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Scott Kopetz Paulo M Hoff; Jeffrey S Morris; Robert A Wolff; Cathy Eng; Katrina Y Glover; Rosie Adinin; Michael J Overman; Vincete Valero; Sijin Wen; Christopher Lieu; Shaoyu Yan; Hai T Tran; Lee M Ellis; James L Abbruzzese; John V Heymach

Journal of Clinical Oncology New York v. 28, n. 3, p. 453-459, 2010

New York 2010

Acesso online. A biblioteca também possui exemplares impressos.

2
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Scott Kopetz Paulo M Hoff; Jeffrey S Morris; Robert A Wolff; Cathy Eng; Katrina Y Glover; Rosie Adinin; Michael J Overman; Vincete Valero; Sijin Wen; Christopher Lieu; Shaoyu Yan; Hai T Tran; Lee M Ellis; James L Abbruzzese; John V Heymach

Journal of Clinical Oncology New York v. 28, n. 3, p. 453-459, 2010

New York 2010

Acesso online. A biblioteca também possui exemplares impressos.

3
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma

PEHAMBERGER, H ; SOYER, H. P ; WOLFF, K ; STEINER, A ; KOFLER, R ; BINDER, M ; MISCHER, P ; PACHINGER, W ; AUBÖCK, J ; FRITSCH, P ; KERL, H

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1425-1429 [Periódico revisado por pares]

Baltimore, MD: Lippincott Williams & Wilkins

Sem texto completo

Citações Citado por
4
Downsizing after palliative systemic chemotherapy with weekly high-dose 5-fluorouracil (5-FU) as a 24h-infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with metastatic adenocarcinomas of the stomach or the gastro-esophageal junction followed by secondary metastatic resection
Downsizing after palliative systemic chemotherapy with weekly high-dose 5-fluorouracil (5-FU) as a 24h-infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with metastatic adenocarcinomas of the stomach or the gastro-esophageal junction followed by secondary metastatic resection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Downsizing after palliative systemic chemotherapy with weekly high-dose 5-fluorouracil (5-FU) as a 24h-infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with metastatic adenocarcinomas of the stomach or the gastro-esophageal junction followed by secondary metastatic resection

Koucky, K. ; Boxberger, F. ; Albrecht, H. ; Maennlein, G. ; Wolff, K. ; Ostermeier, N. ; Schildberg, C. ; Golcher, H. ; Hohenberger, W. ; Hahn, E. G. ; Wein, A.

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15585-e15585 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Palliative first-line treatment with weekly high-dose 5-fluorouracil and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus biweekly oxaliplatin (ox) in patients with definitively non-resectable metastatic colorectal cancer (CRC) following secondary (sec.) metastatic resection: An interdisciplinary phase II trial
Palliative first-line treatment with weekly high-dose 5-fluorouracil and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus biweekly oxaliplatin (ox) in patients with definitively non-resectable metastatic colorectal cancer (CRC) following secondary (sec.) metastatic resection: An interdisciplinary phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Palliative first-line treatment with weekly high-dose 5-fluorouracil and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus biweekly oxaliplatin (ox) in patients with definitively non-resectable metastatic colorectal cancer (CRC) following secondary (sec.) metastatic resection: An interdisciplinary phase II trial

Albrecht, H. ; Boxberger, F. ; Wolff, K. ; Ostermeier, N. ; Reulbach, U. ; Maennlein, G. ; Meyer, T. ; Hohenberger, W. ; Hahn, E. G. ; Wein, A.

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15073-e15073 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Palliative systemic chemotherapy with gemcitabine (GEM) and 5-fluorouracil (5-FU) as 24h-infusion in patients with advanced inoperable biliary tract cancer (UICC stage IV)
Palliative systemic chemotherapy with gemcitabine (GEM) and 5-fluorouracil (5-FU) as 24h-infusion in patients with advanced inoperable biliary tract cancer (UICC stage IV)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Palliative systemic chemotherapy with gemcitabine (GEM) and 5-fluorouracil (5-FU) as 24h-infusion in patients with advanced inoperable biliary tract cancer (UICC stage IV)

Kersten, S. ; Wein, A. ; Albrecht, H. ; Reulbach, U. ; Maennlein, G. ; Wolff, K. ; Ostermeier, N. ; Hohenberger, W. ; Hahn, E. G. ; Boxberger, F.

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15633-e15633 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group

Pehamberger, H ; Soyer, H P ; Steiner, A ; Kofler, R ; Binder, M ; Mischer, P ; Pachinger, W ; Auböck, J ; Fritsch, P ; Kerl, H ; Wolff, K

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1425-1429 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
8
Palliative first-line treatment with weekly high-dose 5-fluorouracil (5-FU) and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus biweekly oxaliplatin (ox) in patients with definitively nonresectable metastatic colorectal cancer (CRC) following secondary (sec) metastatic resection: An interdisciplinary phase II trial
Palliative first-line treatment with weekly high-dose 5-fluorouracil (5-FU) and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus biweekly oxaliplatin (ox) in patients with definitively nonresectable metastatic colorectal cancer (CRC) following secondary (sec) metastatic resection: An interdisciplinary phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Palliative first-line treatment with weekly high-dose 5-fluorouracil (5-FU) and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus biweekly oxaliplatin (ox) in patients with definitively nonresectable metastatic colorectal cancer (CRC) following secondary (sec) metastatic resection: An interdisciplinary phase II trial

Albrecht, H. ; Wein, A. ; Wolff, K. ; Brueckl, V. ; Meier, C. ; Ostermeier, N. ; Maennlein, G. ; Hahn, E. G. ; Reulbach, U. ; Hohenberger, W. ; Boxberger, F.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.15064-15064 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Weekly high-dose 5-FU as a 24h-infusion and sodium folinic acid (AIO regimen) plus Irinotecan in patients with locally advanced non-resectable and metastatic adenocarcinoma or squamous epithelial carcinoma of the esophagus: Analysis of a phase II trial
Weekly high-dose 5-FU as a 24h-infusion and sodium folinic acid (AIO regimen) plus Irinotecan in patients with locally advanced non-resectable and metastatic adenocarcinoma or squamous epithelial carcinoma of the esophagus: Analysis of a phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly high-dose 5-FU as a 24h-infusion and sodium folinic acid (AIO regimen) plus Irinotecan in patients with locally advanced non-resectable and metastatic adenocarcinoma or squamous epithelial carcinoma of the esophagus: Analysis of a phase II trial

Boxberger, F. ; Wolff, K. ; Brueckl, V. ; Brueckl, W. M. ; Albrecht, H. ; Engel, M. ; Maennlein, G. ; Mach, K. ; Hohenberger, W. ; Hahn, E. G. ; Wein, A.

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15051-15051 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
10
Weekly high-dose 5-FU as 24h-infusion and folinic acid (AIO regimen) plus Irinotecan in patients with advanced non-resectable adenocarcinoma or squamous epithelial carcinoma of the oesophagus: Interim analysis of a phase II trial
Weekly high-dose 5-FU as 24h-infusion and folinic acid (AIO regimen) plus Irinotecan in patients with advanced non-resectable adenocarcinoma or squamous epithelial carcinoma of the oesophagus: Interim analysis of a phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly high-dose 5-FU as 24h-infusion and folinic acid (AIO regimen) plus Irinotecan in patients with advanced non-resectable adenocarcinoma or squamous epithelial carcinoma of the oesophagus: Interim analysis of a phase II trial

Boxberger, F. ; Wolff, K. ; Brueckl, V. ; Brueckl, W. M. ; Meier, C. ; Maennlein, G. ; Horbach, T. ; Hohenberger, W. ; Hahn, E. G. ; Wein, A.

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14109-14109 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Autor/Criador 

  1. Abbruzzese, J  (2)
  2. Ellis, L  (2)
  3. Yan, S  (2)
  4. Adinin, R  (2)
  5. Wen, S  (2)
  6. Overman, M  (2)
  7. Kopetz, S  (2)
  8. Hoff, P  (2)
  9. Valero, V  (2)
  10. Tran, H  (2)
  11. Eng, C  (2)
  12. Lieu, C  (2)
  13. Heymach, J  (2)
  14. Wolff, R  (2)
  15. Glover, K  (2)
  16. Morris, J  (2)
  17. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1990  (7)
  2. 1990Até2002  (10)
  3. 2003Até2009  (30)
  4. 2010Até2016  (42)
  5. Após 2016  (31)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Abbruzzese, J
  2. Ellis, L
  3. Yan, S
  4. Adinin, R
  5. Wen, S

Neste Assunto:

  1. Life Sciences & Biomedicine
  2. Science & Technology
  3. Oncology
  4. Humans
  5. Female

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.